Hepatitis B Virus Reactivation following Allogeneic Hematopoietic Stem Cell Transplantation
Sarah P. Hammond(Dana-Farber Cancer Institute), Francisco M. Marty(Brigham and Women's Hospital), Anne Marie Borchelt(Brigham and Women's Hospital), Chinweike Ukomadu(Brigham and Women's Hospital), Lindsey R. Baden(Brigham and Women's Hospital), Vincent T. Ho(Brigham and Women's Hospital)
Cited by 144
Related Papers
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981